BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 26161511)

  • 1. Treatment of hepatitis C-related kidney disease.
    Fabrizi F; Martin P; Cacoub P; Messa P; Donato FM
    Expert Opin Pharmacother; 2015; 16(12):1815-27. PubMed ID: 26161511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus infection and glomerular disease.
    Fabrizi F; Donato F; Messa P
    Minerva Urol Nefrol; 2014 Jun; 66(2):139-49. PubMed ID: 24988205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatitis C-virus-related glomerulonephritis.
    Kamar N; Rostaing L; Alric L
    Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
    Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK
    Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.
    Fabrizi F; Lunghi G; Messa P; Martin P
    J Nephrol; 2008; 21(6):813-25. PubMed ID: 19034865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
    Garini G; Allegri L; Carnevali L; Catellani W; Manganelli P; Buzio C
    Am J Kidney Dis; 2001 Dec; 38(6):E35. PubMed ID: 11728995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus associated glomerulopathies.
    Ozkok A; Yildiz A
    World J Gastroenterol; 2014 Jun; 20(24):7544-54. PubMed ID: 24976695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steroids, interferon-alpha and ribavirin treatment of cryoglobulinemic glomerulonephritis concurrent with HCV infection].
    Guarnieri A; Marazzi F; Giorgi MP; Canepari G; Pino C; Moggia E; Manca A; Ghezzi PM
    G Ital Nefrol; 2002; 19(1):79-81. PubMed ID: 12165950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies.
    Garini G; Allegri L; Lannuzzella F; Vaglio A; Buzio C
    Acta Biomed; 2007; 78(1):51-9. PubMed ID: 17687818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy.
    Morales JM; Kamar N; Rostaing L
    Contrib Nephrol; 2012; 176():10-23. PubMed ID: 22310777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease.
    Fabrizi F; Plaisier E; Saadoun D; Martin P; Messa P; Cacoub P
    Am J Kidney Dis; 2013 Apr; 61(4):623-37. PubMed ID: 23102733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral therapy of symptomatic HCV-mixed cryoglobulinemia after liver transplant: case report and literature review.
    Francesca Donato M; Banfi G; Cresseri D; Battista Fogazzi G; Martin P; Messa P; Fabrizi F
    Int J Artif Organs; 2013 May; 36(5):367-72. PubMed ID: 23446762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
    Laurino S; Borrelli S; Catapano F; Mascia S; D'Angio' P; Calabria M; Grimaldi M; Salvio A; Minutolo R; De Nicola L; Conte G
    G Ital Nefrol; 2009; 26(3):318-27. PubMed ID: 19554529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
    Alric L; Plaisier E; Thébault S; Péron JM; Rostaing L; Pourrat J; Ronco P; Piette JC; Cacoub P
    Am J Kidney Dis; 2004 Apr; 43(4):617-23. PubMed ID: 15042538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kidney involvement in mixed cryoglobulinemia: which treatment?].
    Cacoub P
    Presse Med; 2012 Mar; 41(3 Pt 1):254-9. PubMed ID: 22192935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.
    Rutledge SM; Chung RT; Sise ME
    Hemodial Int; 2018 Apr; 22 Suppl 1():S81-S96. PubMed ID: 29694729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
    Ahmed MS; Wong CF
    J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritis.
    De Nicola S; Aghemo A; Campise MR; D'Ambrosio R; Rumi MG; Messa P; Colombo M
    Antivir Ther; 2014; 19(5):527-31. PubMed ID: 24009104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4.
    Elmowafy AY; El Maghrabi HM; Zahab MA; Elwasif SM; Bakr MA
    Iran J Kidney Dis; 2018 Nov; 12(6):382-384. PubMed ID: 30595569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.